-
EMUC25 in review: Key takeaways and expert insights
December 16, 2025The 17th European Multidisciplinary Congress on Urological Cancers (EMUC25) delivered critical developments in the treatment and management of genitourinary...
0 -
Expert interviews from EMUC25
November 20, 2025At EMUC25 in Prague last month, editorial board members of the UROONCO Educational Platform recorded a series of in‑depth...
-
EMUC25 examines BRCA and PRS in hereditary GU cancers session
November 15, 2025What are the current updates regarding the significantly elevated prostate cancer (PCa) risk in individuals with BRCA mutations? What...
-
The big PCa game-changers for 2025
November 15, 2025In an auditorium packed to capacity, Dr. Elena Castro (ES), Prof. Axel Merseburger (DE), and Dr. Alison Tree (GB),...
-
The future of finding cancer: Detecting earlier
November 13, 2025During the second session by the EAU Section on Urological Imaging on Day 1 at EMUC25 in Prague, presenters...
-
No compromises: GU-cancer care can be effective, equitable, accessible, and sustainable by 2050
September 3, 2025This year’s 17th European Multidisciplinary Congress on Urological Cancers (EMUC25) will tackle one of the most pressing questions in...
-
What were the big game changers for 2024?
November 9, 2024Chaired by Prof. Axel Merseburger (DE), Dr. Alison Tree (GB) and Prof. Jan Oldenburg (NO), the game-changing session on...
-
Stepping into their shoes: EU-ProPER studies partners of PCa patients
November 8, 2024What is the extent of the physical and psychological burdens that prostate cancer (PCa) imposes on the partners of...
-
Integrating AI for PCa screening and diagnosis: ProCancer-I
November 7, 2024During the first session by the EAU Section on Urological Imaging on Day 1 at EMUC24 in Lisbon, biomedical...
-
2023 ends with big game changers for GU cancers
November 4, 2023Chaired by Prof. Axel Merseburger (DE), Prof. Karim Fizazi (FR) and Prof. Valerie Fonteyne (BE), the game-changing session on...
